Clinical Trial Update: Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated valopicitabine alone and in combination with pegylated interferon in patients with chronic hepatitis C who failed standard th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Valopicitabine (valopicitabine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED